Target intelligence / Profile preview

Tropomyosin receptor kinase A and p75 neurotrophin receptor (TrkA/p75NTR)

Target
TrkA/p75NTR
Molecular classification
Receptor tyrosine kinase, Tumor necrosis factor receptor superfamily, Receptor
01

Overview

The TrkA/p75NTR neurotrophin receptor system is a dual-receptor complex composed of the high-affinity tropomyosin receptor kinase A (TrkA) and the p75 neurotrophin receptor (p75NTR), which together coordinate the cellular response to nerve growth factor (NGF) (NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570488/). TrkA is a receptor tyrosine kinase that, upon NGF binding, activates intracellular cascades such as the PI3K/Akt and MAPK/ERK pathways to promote neuronal survival, differentiation, and neurite outgrowth (PatSnap, https://patsnap.com). The p75NTR, a member of the tumor necrosis factor receptor superfamily, acts as a co-receptor that increases the affinity and specificity of TrkA for NGF, but it can also signal independently to trigger apoptosis or growth cone collapse, particularly when activated by pro-neurotrophins (Wikipedia, https://en.wikipedia.org/wiki/P75_neurotrophin_receptor). This receptor system is a significant therapeutic target in oncology, where NTRK1 gene fusions act as oncogenic drivers, and in chronic pain management, where NGF-mediated signaling contributes to peripheral and central sensitization (NIH, https://pubmed.ncbi.nlm.nih.gov/26372482/). Drugs targeting this system include selective TrkA inhibitors like larotrectinib and entrectinib for cancer, and anti-NGF monoclonal antibodies like tanezumab for chronic pain (NIH, https://pubmed.ncbi.nlm.nih.gov/31112321/). However, therapeutic intervention must balance clinical benefits against safety concerns, such as neurological side effects for kinase inhibitors and rapidly progressive osteoarthritis for anti-NGF therapies (NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254551/).

Other names
NTRK1NGFRCD271High-affinity nerve growth factor receptorLow-affinity nerve growth factor receptorp75 neurotrophin receptorTropomyosin receptor kinase ALNGFRTrkA
02

Mechanism of action

Inhibition of TrkA tyrosine kinase activity; Sequestration of NGF to prevent receptor binding; Modulation of p75NTR-mediated apoptotic or survival signaling.

03

Biological functions

Signal transductionCell survivalApoptosisNeuronal differentiationAxonal growthSynaptic plasticityNociception
04

Disease associations

CancerNeurodegenerative diseaseChronic painInflammationAlzheimer's disease
05

Safety considerations

Neurological side effects (dizziness, ataxia)Weight gainRapidly progressive osteoarthritis (RPOA)OsteonecrosisParesthesia
06

Interacting drugs

Larotrectinib

7 more in the full profile.

07

Biomarkers

NTRK1 gene fusionNTRK1 mutationp75NTR (CD271) expressionNGF levels

Beyond the preview

Go deeper on Tropomyosin receptor kinase A and p75 neurotrophin receptor (TrkA/p75NTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tropomyosin receptor kinase A and p75 neurotrophin receptor (TrkA/p75NTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call